Gravar-mail: VIROLOGIC AND IMMUNOLOGIC OUTCOMES IN HIV-INFECTED CAMBODIAN CHILDREN AFTER 18 MONTHS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)